- Home
- IPAR vs CRNX Comparison
IPAR vs CRNX Comparison
Compare IPAR & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPAR
- CRNX
- Stock Information
- Founded
- IPAR 1982
- CRNX 2008
- Country
- IPAR United States
- CRNX United States
- Employees
- IPAR N/A
- CRNX N/A
- Industry
- IPAR Package Goods/Cosmetics
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- IPAR Consumer Discretionary
- CRNX Health Care
- Exchange
- IPAR Nasdaq
- CRNX Nasdaq
- Market Cap
- IPAR 3.1B
- CRNX 2.8B
- IPO Year
- IPAR 1988
- CRNX 2018
- Fundamental
- Price
- IPAR $89.41
- CRNX $43.28
- Analyst Decision
- IPAR Strong Buy
- CRNX Buy
- Analyst Count
- IPAR 5
- CRNX 12
- Target Price
- IPAR $154.60
- CRNX $74.45
- AVG Volume (30 Days)
- IPAR 238.5K
- CRNX 1.5M
- Earning Date
- IPAR 11-05-2025
- CRNX 11-06-2025
- Dividend Yield
- IPAR 3.49%
- CRNX N/A
- EPS Growth
- IPAR 14.29
- CRNX N/A
- EPS
- IPAR 5.02
- CRNX N/A
- Revenue
- IPAR $1,458,888,000.00
- CRNX $1,392,000.00
- Revenue This Year
- IPAR $4.18
- CRNX $420.79
- Revenue Next Year
- IPAR $5.35
- CRNX $993.85
- P/E Ratio
- IPAR $18.27
- CRNX N/A
- Revenue Growth
- IPAR 7.04
- CRNX 0.51
- 52 Week Low
- IPAR $91.06
- CRNX $24.10
- 52 Week High
- IPAR $148.15
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- IPAR 33.87
- CRNX 54.21
- Support Level
- IPAR $91.06
- CRNX $41.12
- Resistance Level
- IPAR $100.73
- CRNX $44.54
- Average True Range (ATR)
- IPAR 2.71
- CRNX 1.91
- MACD
- IPAR 0.16
- CRNX -0.37
- Stochastic Oscillator
- IPAR 15.36
- CRNX 43.15
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.